Abstract:The gold(I)N‐heterocyclic‐carbene complexes containing 6‐mercaptopurine derivatives revealed promising in vitro cytotoxicity against selected human cancer cells. The effects of the complexes on the production of pro‐inflammatory cytokine TNF‐α and the activation of NF‐κB or PPARγ are negligible. Cellular effects of complexes were evaluated on A2780 cells, including cell cycle modification, induction of cell death, mitochondrial membrane potential, and ROS. The proteomic analysis revealed the effects of the complexes on the proteome of A2780 cells. A series of eight N‐heterocyclic carbenes (NHC) gold(I) complexes, involving 1,3‐bis(2,6‐diisopropylphenyl)imidazol‐2‐ylidene (iPr) ligand in combination with 6‐mercaptopurine derivatives (HL1–8), has been prepared and thoroughly characterized, including elemental analysis, mass spectrometry, infrared and multinuclear NMR spectroscopy, and single crystal X‐ray analysis. The complexes, showing general composition of [Au (iPr)(Ln)] 1–8, were evaluated for their in vitro cytotoxicity against four human cancer cell lines including A2780 (ovarian) and A2780R (ovarian Cisplatin resistant), PC3 (prostate) and MCF‐7 (breast), and normal human MRC‐5 cells (lung fibroblasts). The complexes revealed significant cytotoxicity, with the best IC50 values ≈ 3.4–6.4 μM against A2780 and reasonable selectivity. Cellular effects of the selected complexes on the A2780 cells were evaluated using various flow cytometry assays. Complexes 1, 3, and 4 showed a strong pro‐apoptotic effect and a strong effect on the loss of mitochondrial membrane potential. These findings indicate that their major mechanism of action is based on the collapse of the mitochondrial metabolism and activation of the intrinsic signaling pathway of apoptosis, consequently resulting in cell death. The complexes 1–8 revealed only negligible effect on the production of inflammatory‐related cytokine (TNF‐α), as well as the activation of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) or peroxisome proliferator‐activated receptor gamma (PPARγ). Moreover, the shotgun proteomic analysis was performed, and the obtained results suggest that the mechanism of action of complexes 1, 3, and 4 differs somewhat from that of Auranofin.

Au⋅⋅⋅H−X (X=N or C) Intramolecular Interactions in Gold (I)‐NHC Carbene Complexes with Potential Anticancer Properties: A Quantum Mechanical Study with Two Basis Sets

Gold(I) organometallics with alkynyl and N-heterocyclic carbene ligands and their medicinal and computational chemistry evaluation as prospective anticancer drugs

Structure-base design to explore the anticancer efficacy of organometallic Pt(II)- and Au(III)-N-heterocyclic carbene (NHC) complexes

Exploring the Anticancer Activity of Gold Complex with Newly Ligand (DDIBM): Synthesis, Spectral Identification and Magnetic Susceptibility of Its Metallic Complexes

Primary amino-functionalized N-heterocyclic carbene ligands as support for Au(I)···Au(I) interactions: structural, electrochemical, spectroscopic and computational studies of the dinuclear [Au2(NH2(CH2)2imMe)2][NO3]2

Exploring the bonding and aromaticity of [Au3{C2H2N2E(L)}3]+ (E = Si, Ge and L = –CH3, -H, -CF3, –NO2): Trinuclear gold superalkali complexes

Intermolecular Interactions Between Gold Clusters and Selected Amino Acids Cysteine and Glycine: a DFT Study.

Crystal Design, Antitumor Activity and Molecular Docking of Novel Palladium(II) and Gold(III) Complexes with a Thiosemicarbazone Ligand

Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches

Quantum chemical studies of the electronic structures of anti-tumor agents: Au<SUP>III</SUP>L+ (L = porphine, tetraphenylporphyrin)

Steric and Electronic Effects in N-Heterocyclic Carbene Gold(III) Complexes: An Experimental and Computational Study

Gold(I) N‐heterocyclic carbene (NHC) complexes containing 6‐mercaptopurine derivatives and their in vitro anticancer and anti‐inflammatory effects

In-vitro and in-vivo investigations into the carbene-gold anticancer drug candidates NHC-Au-SCSNMe2 and NHC-Au-S-GLUC against advanced prostate cancer PC3

Novel Au(Iii) Complexes Of Aminoquinoline Derivatives: Crystal Structure, Dna Binding And Cytotoxicity Against Melanoma And Lung Tumour Cells

Understanding the bonding and aromaticity of [Au3{C4H4(X)4E}3]- (X=CF3, CN, BO; E= Si, Ge): a trinuclear gold superhalogens

Chemical bonding in some anticancer NHC complexes [RʹC≡C → ML] (M=Cu (I), Ag (I), Au (I); Rʹ=C10H7 and C9NH12SO2; L=NHC (R) and P (R)3; and R=F, Cl, Br, H, CH3, SiH3, Ph)

Synthesis, Characterization and Anti-Cancer Activity of gold (III) and Nickel (II) Metal Ion Complexes Derived from Tetrazole-Triazole Compound

Catalytic and Pharmacological Activity

Insight into the Nature of Carbon-Metal Bonding of N-Heterocyclic Carbenes in Gold/Silver Complexes and Nanoparticles Using DFT-Correlated Raman Spectroscopy: Strong Evidence for π-Backbonding

On the gold-ligand covalency in linear [AuX2](-) complexes.

Synthesis, characterization, crystal structure and anticancer study of symmetrical binuclear bis-N-heterocyclic carbene silver(I) complexes